Disrupting Virchow's triad: can factor X inhibition reduce risk of adverse outcomes in patients with ischaemic cardiomyopathy?

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-0844|17|7|647-651

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.17, Iss.7, 2015-07, pp. : 647-651

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adding the vessel wall to Virchow's triad

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 58-59

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is Age an Independent Risk Factor of Adverse Drug Reactions in Hospitalized Medical Patients?*

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 39, Iss. 11, 1991-11 ,pp. : 1093-1099

John Wiley & Sons Inc

Access to resources Recommend Favorite

Virchow’s Triad Revisited: Blood Constituents

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 5-6, 2005-01 ,pp. : 449-454

Karger

Access to resources Recommend Favorite

Virchow’s Triad Revisited: Abnormal Flow

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 5-6, 2005-01 ,pp. : 455-457

Karger

Access to resources Recommend Favorite

Mammalian target of rapamycin inhibition after solid organ transplantation: can it, and does it, reduce cancer risk?

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 7, 2015-07 ,pp. : 654-663

John Wiley & Sons Inc

Access to resources Recommend Favorite